99% Savings - Buy Just @1 Rs X
Tenofovir + Emtricitabine Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Tenofovir + Emtricitabine Tablet is used -
Moderate
Mild
Is the use of Tenofovir + Emtricitabine Tablet safe for pregnant women?
Tenofovir + Emtricitabine is safe for pregnant women.
Is the use of Tenofovir + Emtricitabine Tablet safe during breastfeeding?
Tenofovir + Emtricitabine is completely safe for breastfeeding women.
What is the effect of Tenofovir + Emtricitabine Tablet on the Kidneys?
Tenofovir + Emtricitabine may have mild side effects on the kidneys.
What is the effect of Tenofovir + Emtricitabine Tablet on the Liver?
Tenofovir + Emtricitabine has very mild side effects on the liver.
What is the effect of Tenofovir + Emtricitabine Tablet on the Heart?
Using Tenofovir + Emtricitabine does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Tenofovir + Emtricitabine Tablet unless your doctor advises you to do so -
Is this Tenofovir + Emtricitabine Tablet habit forming or addictive?
Tenofovir + Emtricitabine Tablet is not addictive in nature.
Interaction between Food and Tenofovir + Emtricitabine Tablet
You can take Tenofovir + Emtricitabine Tablet with food.
Interaction between Alcohol and Tenofovir + Emtricitabine Tablet
Consuming Tenofovir + Emtricitabine Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1179
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 803-804
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Viread® (tenofovir disoproxil fumarate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Emtriva®(emtricitabine)